Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2017

Ausgabe 2/2017

Inhaltsverzeichnis ( 33 Artikel )

28.07.2017 | Review | Ausgabe 2/2017 Open Access

Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients

Muneer Ahmed, F. Jozsa, R. Baker, I. T. Rubio, J. Benson, M. Douek

30.08.2017 | Erratum | Ausgabe 2/2017

Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients

Muneer Ahmed, F. Jozsa, R. Baker, I. T. Rubio, J. Benson, M. Douek

31.07.2017 | Review | Ausgabe 2/2017

Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature

Fausto Petrelli, Gianluca Tomasello, Sandro Barni, Veronica Lonati, Rodolfo Passalacqua, Michele Ghidini

04.08.2017 | Review | Ausgabe 2/2017

Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants

Kiven Erique Lukong, Yetunde Ogunbolude, Jean Paul Kamdem

12.08.2017 | Review | Ausgabe 2/2017

Does obesity modify the relationship between physical activity and breast cancer risk?

S. E. Neil-Sztramko, T. Boyle, E. Milosevic, S. F. Nugent, C. C. Gotay, K. L. Campbell

28.07.2017 | Preclinical study | Ausgabe 2/2017

Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast

Fanfan Meng, Bingbing Liu, Gan Xie, Yawen Song, Xia Zheng, Xiaolong Qian, Shuai Li, Hongqin Jia, Xinmin Zhang, Lanjing Zhang, Yi-ling Yang, Li Fu

29.07.2017 | Preclinical study | Ausgabe 2/2017

Therapeutic blockade of Foxp3 in experimental breast cancer models

Mariela A. Moreno Ayala, María Florencia Gottardo, Mercedes Imsen, Antonela S. Asad, Elisa Bal de Kier Joffé, Noelia Casares, Juan José Lasarte, Adriana Seilicovich, Marianela Candolfi

05.08.2017 | Preclinical Study | Ausgabe 2/2017

Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer

Cecilia L. Speyer, Miriam A. Bukhsh, Waris S. Jafry, Rachael E. Sexton, Sudeshna Bandyopadhyay, David H. Gorski

08.08.2017 | Preclinical study | Ausgabe 2/2017

Metalloprotease-dependent activation of EGFR modulates CD44+/CD24− populations in triple negative breast cancer cells through the MEK/ERK pathway

Randi Wise, Anna Zolkiewska

09.08.2017 | Preclinical study | Ausgabe 2/2017

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study

Toni Roeke, Marcelo Sobral-Leite, Tim J. A. Dekker, Jelle Wesseling, Vincent T. H. B. M. Smit, Rob A. E. M. Tollenaar, Marjanka K. Schmidt, Wilma E. Mesker

10.08.2017 | Preclinical study | Ausgabe 2/2017

HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma

Yanjun Hou, Hiroaki Nitta, Lai Wei, Peter M. Banks, Bryce Portier, Anil V. Parwani, Zaibo Li

31.07.2017 | Clinical trial | Ausgabe 2/2017 Open Access

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

M. J. Fischer, K. Inoue, A. Matsuda, J. R. Kroep, S. Nagai, K. Tozuka, M. Momiyama, N. I. Weijl, D. Langemeijer-Bosman, S. R. S. Ramai, J. W. R. Nortier, H. Putter, K. Yamaoka, K. Kubota, K. Kobayashi, A. A. Kaptein

01.08.2017 | Clinical Trial | Ausgabe 2/2017

Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy

Young-Joon Kang, Wonshik Han, Soojin Park, Ji Young You, Ha Woo Yi, Sungmin Park, Sanggeun Nam, Joo Heung Kim, Keong Won Yun, Hee Jeong Kim, Sei Hyun Ahn, Seho Park, Jeong Eon Lee, Eun Sook Lee, Dong-Young Noh, Jong Won Lee

01.08.2017 | Clinical trial | Ausgabe 2/2017 Open Access

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

S. Alkner, M.-B. Jensen, B. B. Rasmussen, P.-O. Bendahl, M. Fernö, L. Rydén, H. Mouridsen, Danish Breast Cancer Cooperative Group

02.08.2017 | Clinical trial | Ausgabe 2/2017

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Qamar J. Khan, Bruce F. Kimler, Pavan S. Reddy, Priyanka Sharma, Jennifer R. Klemp, Jennifer L. Nydegger, Hung-Wen Yeh, Carol J. Fabian

05.08.2017 | Clinical trial | Ausgabe 2/2017

Clinical implementation of synthesized mammography with digital breast tomosynthesis in a routine clinical practice

Phoebe E. Freer, Joanna Riegert, Laura Eisenmenger, Dominik Ose, Nicole Winkler, Matthew A. Stein, Gregory J. Stoddard, Rachel Hess

07.08.2017 | Clinical trial | Ausgabe 2/2017

Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients

Ji Hyeon Joo, Su Ssan Kim, Seung-Do Ahn, Eun Kyung Choi, Jin Hong Jung, Yuri Jeong, Sei Hyun Ahn, Byung Ho Son, Jong Won Lee, Hee Jung Kim, Beom Seok Go, Hak Hee Kim, Joo Hee Cha, Hee Jung Shin, Eun Young Chae

08.08.2017 | Clinical trial | Ausgabe 2/2017

Long-term peripheral neuropathy symptoms in breast cancer survivors

Moaath Mustafa Ali, Machelle Moeller, Lisa Rybicki, Halle C. F. Moore

09.08.2017 | Clinical trial | Ausgabe 2/2017 Open Access

IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer

Carlo Palmieri, Richard Szydlo, Marie Miller, Laura Barker, Neva H. Patel, Hironobu Sasano, Tara Barwick, Henry Tam, Dimitri Hadjiminas, Jasmin Lee, Abeer Shaaban, Hanna Nicholas, R. Charles Coombes, Laura M. Kenny

11.08.2017 | Clinical trial | Ausgabe 2/2017

Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study

Anne Blaes, Heather Beckwith, Natalia Florea, Robert Hebbel, Anna Solovey, David Potter, Douglas Yee, Rachel Vogel, Russell Luepker, Daniel Duprez

27.07.2017 | Epidemiology | Ausgabe 2/2017

Association between survival time with metastatic breast cancer and aggressive end-of-life care

Melissa K. Accordino, Jason D. Wright, Sowmya Vasan, Alfred I. Neugut, Tal Gross, Grace C. Hillyer, Dawn L. Hershman

29.07.2017 | Epidemiology | Ausgabe 2/2017

FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?

Allyson C. Espinal, Matthew F. Buas, Dan Wang, David Ting-Yuan Cheng, Lara Sucheston-Campbell, Qiang Hu, Li Yan, Rochelle Payne-Ondracek, Eduardo Cortes, Li Tang, Zhihong Gong, Gary Zirpoli, Thaer Khoury, Song Yao, Angela Omilian, Kitaw Demissie, Elisa V. Bandera, Song Liu, Christine B. Ambrosone, Michael J. Higgins

02.08.2017 | Epidemiology | Ausgabe 2/2017

Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients

Ke Zheng, Jin-Xiang Tan, Fan Li, Yu-Xian Wei, Xue-Dong Yin, Xin-Liang Su, Hong-Yuan Li, Qi-Lun Liu, Bin-Lin Ma, Jiang-Hua Ou, Hui Li, Sui-Sheng Yang, Ai-Mei Jiang, Qing Ni, Jian-Lun Liu, Jin-Ping Liu, Hong Zheng, Zhang-Jun Song, Ling Wang, Jian-Jun He, Tian-Ning Zou, Jun Jiang, Guo-Sheng Ren

03.08.2017 | Epidemiology | Ausgabe 2/2017

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013

Yasuaki Sagara, Rachel A. Freedman, Stephanie M. Wong, Fatih Aydogan, Anvy Nguyen, William T. Barry, Mehra Golshan

04.08.2017 | Epidemiology | Ausgabe 2/2017 Open Access

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk

Laura J. van ‘t Veer, Christina Yau, Nancy Y. Yu, Christopher C. Benz, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Laura J. Esserman, Linda Sofie Lindström

08.08.2017 | Epidemiology | Ausgabe 2/2017

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C. Gard, Jessica W. T. Leung, Jeffrey A. Tice, Elad Ziv, Karla Kerlikowske, Steven R. Cummings

08.08.2017 | Epidemiology | Ausgabe 2/2017

Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study

Megan A. Healey, Kelly A. Hirko, Andrew H. Beck, Laura C. Collins, Stuart J. Schnitt, A. Heather Eliassen, Michelle D. Holmes, Rulla M. Tamimi, Aditi Hazra

01.08.2017 | Brief Report | Ausgabe 2/2017

Detection of multicentric and contralateral breast cancers on MRI based on primary cancer biomarker status: will this change surgical or medical management?

Arti R. Jonna, Kenny Q. Sam, Lilian O. Ebuoma, Emily L. Sedgwick, Tao Wang, Ana P. Benveniste

05.08.2017 | Brief Report | Ausgabe 2/2017

Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

Carole Corsini, Sarra Henouda, Dalel Ben Nejima, Héléna Bertet, Alain Toledano, Hamouda Boussen, Faouzi Habib, Asma Mouhout, Ahmed Gaballah, Hesham El Ghazaly, Céline Bourgier, Isabelle Coupier, Virginie Galibert, Karen Baudry, Paul Vilquin, Louise Biquard, Jean-Marc Rey, Yazid Belkacemi, Paul Ihout, David Khayat, Marie-Christine Picot, Assia Bensalem, Pascal Pujol

10.08.2017 | Brief Report | Ausgabe 2/2017 Open Access

NanoString-based breast cancer risk prediction for women with sclerosing adenosis

Stacey J. Winham, Christine Mehner, Ethan P. Heinzen, Brendan T. Broderick, Melody Stallings-Mann, Aziza Nassar, Robert A. Vierkant, Tanya L. Hoskin, Ryan D. Frank, Chen Wang, Lori A. Denison, Celine M. Vachon, Marlene H. Frost, Lynn C. Hartmann, E. Aubrey Thompson, Mark E. Sherman, Daniel W. Visscher, Amy C. Degnim, Derek C. Radisky

18.08.2017 | Letter to the Editor | Ausgabe 2/2017

Attitudes of female staff and students from two United Kingdom Medical Schools towards donating normal healthy breast tissue and blood samples for biomedical research

Harriet Wilson, Valerie Speirs

30.08.2017 | Letter to the Editor | Ausgabe 2/2017

Reply to Kopans

Steven A. Narod

16.09.2017 | Rebuttal Letter | Ausgabe 2/2017

Rebuttal comments

Daniel B. Kopans

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise